Table 3.
Use of other medications
| |
Control |
CRC |
|
||
|---|---|---|---|---|---|
| n (%) | n (%) | OR | (95% CI) | p-value | |
| aspirin |
43 (32.6) |
15 (14.9) |
0.36 |
(0.18 -.70) |
< 0.01 |
| NSAIDs |
16 (12.1) |
7 (6.9) |
0.54 |
(0.20 -1.35) |
0.19 |
| CCMs* |
12 (9.1) |
7 (6.9) |
0.75 |
(0.27 – 1.97) |
0.55 |
| metformin |
18 (13.6) |
5 (5.0) |
0.33 |
(0.10 -0.89) |
0.03 |
| other diabetes | 8 (6.1) | 1 (1.0) | 0.16 | (0.03 – 1.19) | 0.06 |
Use of medications in patients with colorectal cancer (CRC) and controls. Results expressed as odds ratio with 95% confidence intervals (95% CI). *calcium channel modulators.